...
首页> 外文期刊>BMC Women s Health >Fine needle aspiration cytology of lymph nodes in breast cancer follow-up is a feasible alternative to watchful waiting and to histology
【24h】

Fine needle aspiration cytology of lymph nodes in breast cancer follow-up is a feasible alternative to watchful waiting and to histology

机译:乳腺癌随访中淋巴结的细针穿刺细胞学检查是观察等待和组织学检查的可行替代方法

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Early detection of loco-regional breast cancer recurrence improves patients’ overall survival, as treatment can be initiated or active treatment can be changed. If a suspicious lymph node is diagnosed during a follow-up exam, surgical excision is often performed. The aim of this study was to evaluate the diagnostic performance of the minor invasive ultrasound-guided fine-needle aspiration cytology (FNAC) in sonomorphologically suspicious lymph nodes in breast cancer follow-up. Between April 2010 and November 2012, we performed ultrasound-guided FNAC in 38 sonographically suspicious lymph nodes of 37 breast cancer follow-up patients. Cytological specimens were evaluated if the sample material was sufficient for diagnosis and if they contained cancer cells. Patients with negative cytology were followed up clinically and sonographically. To evaluate the diagnostic performance we calculated sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) for physical examination, the different sonomorphological malignancy criteria and FNAC. In 36/38 (94.7?%) lymph nodes, the pathologist had enough material to establish a final diagnosis; in 2/38 (5.3?%) lymph nodes, the probe material was non-evaluable during cytology, these 2 were excluded from further statistical evaluation. Cytology revealed malignancy in 21 lymph nodes and showed no evidence for malignancy in 15 lymph nodes. There was no evidence for malignant disease in follow-up exams in the 15 cytologically benign lymph nodes with an average follow-up time of 3?years. The diagnostic performances of physical examination and FNAC were: Sensitivity 52/100?%, specificity 88/100?%, PPV 85/100?%, NPV 60/100?%, respectively. Our preliminary results show that FNAC is a safe and fast diagnostic approach for the evaluation of suspicious lymph nodes in the follow-up of patients with breast cancer and, thus, together with follow-up represents a feasible alternative to surgery.
机译:由于可以开始治疗或改变积极治疗,及早发现局部区域性乳腺癌复发可以提高患者的总体生存率。如果在随访检查中诊断出可疑淋巴结,则通常要进行手术切除。这项研究的目的是评估在超声随访中超声引导下的细针穿刺细胞学检查(FNAC)在声纳可疑的淋巴结中的诊断性能。在2010年4月至2012年11月之间,我们对37例乳腺癌随访患者的38例超声检查可疑淋巴结进行了超声引导的FNAC。对细胞学标本进行评估,以确定样品材料是否足以进行诊断以及是否包含癌细胞。细胞学检查阴性的患者将进行临床和超声检查。为了评估诊断性能,我们计算了身体检查的敏感性,特异性,阳性预测值(PPV)和阴性预测值(NPV),不同的声音形态学恶性标准和FNAC。在36/38(94.7%)的淋巴结中,病理学家有足够的材料来进行最终诊断。在2/38(5.3%)的淋巴结中,探针材料在细胞学检查过程中无法评估,这2个被排除在进一步的统计评估之外。细胞学检查显示21个淋巴结有恶性,没有证据表明15个淋巴结有恶性。在15个细胞学上良性淋巴结的随访检查中没有证据表明有恶性疾病,平均随访时间为3年。体格检查和FNAC的诊断性能分别为:敏感性52/100%,特异性88/100%,PPV 85/100%,NPV 60/100%。我们的初步结果表明,FNAC是评估乳腺癌患者随访中可疑淋巴结的一种安全,快速的诊断方法,因此,与随访一起可以替代手术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号